Research focus/interests Goodwin's research focuses on the
neurobiology of
mood disorders, notably
bipolar disorder and its treatment. In addition to developing novel treatments for
mood disorders, Goodwin is interested in the impact of treatments on both the
physiological and
psychological levels, using
brain imaging techniques to study the effects of treatment on brain structure and function as well as the connection between depression and
memory impairment.
Notable contributions to research Goodwin's findings on the impact of depression on brain tissue and memory have led to greater interest in
neurogenesis when developing
antidepressants as well as the role of
cognition in the treatment of depression. Professor Goodwin has been the head of
Oxford University's Department of
Psychiatry since 2006, and a fellow of
Merton College, Oxford since 1996. and the NHS Live Innovation Award with Professor John Geddes for developing the True Colours system that allowed them to remotely monitor the symptoms of their
bipolar patients.
Positions of trust and research assessments Dr. Goodwin is currently President of the
European College of Neuropsychopharmacology (2013–16). From 1997 to 2007, he was the non-executive Director and Vice-Chair of the Oxfordshire and Buckinghamshire
NHS Mental Health Trust Board. Goodwin has served on numerous advisory boards including the Evaluation committee for
neuroscience,
neurology, and
psychiatry of the Agence Nationale de Recherche, France, the
Wellcome Trust Neurosciences Panel, the Council of the British Association for Psychopharmacology, and Medical Research Council's Clinical fellowships panel and Advisory Board. He was elected president of the British Association for Psychopharmacology in 2004–05.
Publications Goodwin has published extensively, authoring a book on
bipolar disorder as well as numerous articles. He also regularly reviews books in the field. ==References==